Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Saved in:
Bibliographic Details
Main Authors: Joensuu, Heikki (Author) , Hohenberger, Peter (Author)
Format: Article (Journal)
Language:English
Published: April 15, 2014
In: Cancer
Year: 2014, Volume: 120, Issue: 15, Pages: 2325–2333
ISSN:1097-0142
DOI:10.1002/cncr.28669
Online Access:Verlag, Volltext: http://dx.doi.org/10.1002/cncr.28669
Verlag, Volltext: http://dx.doi.org/10.1002/cncr.28669I
Get full text
Author Notes:Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; Jörg T. Hartmann, MD; Daniel Pink, MD; Jochen Schütte, MD; Giuliano Ramadori, MD; Peter Hohenberger, MD; Justus Duyster, MD; Salah-Eddin Al-Batran, MD; Marcus Schlemmer, MD; Sebastian Bauer, MD; Eva Wardelmann, MD; Maarit Sarlomo-Rikala, MD; Bengt Nilsson, MD; Harri Sihto, PhD; Karla V. Ballman, PhD; Mika Leinonen, MSci; Ronald P. DeMatteo, MD; and Peter Reichardt, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1550718630
003 DE-627
005 20220813095904.0
007 cr uuu---uuuuu
008 161207s2014 xx |||||o 00| ||eng c
024 7 |a 10.1002/cncr.28669  |2 doi 
035 |a (DE-627)1550718630 
035 |a (DE-576)480718636 
035 |a (DE-599)BSZ480718636 
035 |a (OCoLC)1340945128 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Joensuu, Heikki  |e VerfasserIn  |0 (DE-588)1121118747  |0 (DE-627)873981472  |0 (DE-576)480718318  |4 aut 
245 1 0 |a Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib  |c Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; Jörg T. Hartmann, MD; Daniel Pink, MD; Jochen Schütte, MD; Giuliano Ramadori, MD; Peter Hohenberger, MD; Justus Duyster, MD; Salah-Eddin Al-Batran, MD; Marcus Schlemmer, MD; Sebastian Bauer, MD; Eva Wardelmann, MD; Maarit Sarlomo-Rikala, MD; Bengt Nilsson, MD; Harri Sihto, PhD; Karla V. Ballman, PhD; Mika Leinonen, MSci; Ronald P. DeMatteo, MD; and Peter Reichardt, MD 
264 1 |c April 15, 2014 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 07.12.2016 
700 1 |a Hohenberger, Peter  |d 1953-  |e VerfasserIn  |0 (DE-588)1025311469  |0 (DE-627)72202875X  |0 (DE-576)370195574  |4 aut 
773 0 8 |i Enthalten in  |t Cancer  |d New York, NY : Wiley-Liss, 1948  |g 120(2014), 15, Seite 2325–2333  |h Online-Ressource  |w (DE-627)271350334  |w (DE-600)1479932-7  |w (DE-576)078590884  |x 1097-0142  |7 nnas  |a Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib 
773 1 8 |g volume:120  |g year:2014  |g number:15  |g pages:2325–2333  |g extent:9  |a Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib 
856 4 0 |u http://dx.doi.org/10.1002/cncr.28669  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1002/cncr.28669I  |q application/pdf  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20161207 
993 |a Article 
994 |a 2014 
998 |g 1025311469  |a Hohenberger, Peter  |m 1025311469:Hohenberger, Peter  |d 60000  |d 61800  |e 60000PH1025311469  |e 61800PH1025311469  |k 0/60000/  |k 1/60000/61800/  |p 8 
999 |a KXP-PPN1550718630  |e 2947632788 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am: 07.12.2016"],"person":[{"given":"Heikki","family":"Joensuu","roleDisplay":"VerfasserIn","role":"aut","display":"Joensuu, Heikki"},{"family":"Hohenberger","given":"Peter","roleDisplay":"VerfasserIn","role":"aut","display":"Hohenberger, Peter"}],"physDesc":[{"extent":"9 S."}],"language":["eng"],"recId":"1550718630","relHost":[{"note":["Gesehen am 06.12.2011"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"271350334","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinibCancer","id":{"zdb":["1479932-7"],"doi":["10.1002/(ISSN)1097-0142"],"eki":["271350334"],"issn":["1097-0142"]},"part":{"text":"120(2014), 15, Seite 2325–2333","issue":"15","volume":"120","pages":"2325–2333","year":"2014","extent":"9"},"origin":[{"publisher":"Wiley-Liss","publisherPlace":"New York, NY","dateIssuedKey":"1948","dateIssuedDisp":"1948-"}],"pubHistory":["1.1948 -"],"titleAlt":[{"title":"Cancer cytopathology"}],"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}]}],"id":{"eki":["1550718630"],"doi":["10.1002/cncr.28669"]},"origin":[{"dateIssuedDisp":"April 15, 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; Jörg T. Hartmann, MD; Daniel Pink, MD; Jochen Schütte, MD; Giuliano Ramadori, MD; Peter Hohenberger, MD; Justus Duyster, MD; Salah-Eddin Al-Batran, MD; Marcus Schlemmer, MD; Sebastian Bauer, MD; Eva Wardelmann, MD; Maarit Sarlomo-Rikala, MD; Bengt Nilsson, MD; Harri Sihto, PhD; Karla V. Ballman, PhD; Mika Leinonen, MSci; Ronald P. DeMatteo, MD; and Peter Reichardt, MD"]},"title":[{"title_sort":"Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib","title":"Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a JOENSUUHEIRISKFACTOR1520